Search

DaVita Inc

Ouvert

SecteurSoins de santé

181.44 -0.72

Résumé

Variation du prix de l'action

24h

Actuel

Min

179.69

Max

185.6

Chiffres clés

By Trading Economics

Revenu

68M

343M

Ventes

139M

3.6B

P/E

Moyenne du Secteur

15.543

50.373

BPA

4.02

Marge bénéficiaire

9.657

Employés

78,000

EBITDA

98M

753M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+24.82% upside

Dividendes

By Acuity

Prochains Résultats

1 févr. 2027

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-3.2B

12B

Ouverture précédente

182.16

Clôture précédente

181.44

DaVita Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 nov. 2026, 21:12 UTC

DaVita Inc. is trading modestly lower in after-market hours, continuing a downward trend since Monday's close without significant recovery during the session.

30 oct. 2026, 20:02 UTC

News
Social Media

DaVita Inc. is under pressure after Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential claims on behalf of investors.

29 oct. 2026, 23:02 UTC

Social Media
News

DaVita reports Q3 earnings of $3.82 per share and $3.58 billion in revenue, but shares fall sharply after disappointing full-year guidance and a $62 million impairment charge.

28 oct. 2026, 23:02 UTC

DaVita Inc. is declining in after-market trading, falling significantly below its 20-day moving average and near the lower end of its one-month trading range.

27 oct. 2026, 20:07 UTC

News

DaVita Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, following a U.S. Department of Health announcement affecting the dialysis market.

26 oct. 2026, 19:36 UTC

DaVita Inc shares are trading modestly higher, remaining above their 20-day moving average and near the upper end of their one-month range.

22 oct. 2026, 20:02 UTC

DaVita Inc shares are sharply higher, breaking from a recent trend of higher daily closes and diverging from prior upward momentum.

21 oct. 2026, 20:07 UTC

News

DaVita Inc reaffirmed as a "Buy" with a price target of $265 in a report from DBAB, which sees no significant changes to the HHS kidney care plan.

20 oct. 2026, 23:06 UTC

DaVita Inc shares traded modestly lower in after-market hours, continuing a downward trend from Tuesday's close and remaining below its 20-day moving average.

16 oct. 2026, 19:34 UTC

DaVita Inc shares are declining amid significant market downturns, influenced by stronger-than-expected U.S. industrial production and ongoing inflation concerns.

15 oct. 2026, 20:02 UTC

News

DaVita Inc presents seven studies at ASN Kidney Week 2026, showcasing advancements in kidney care and emphasizing its commitment to clinical research.

14 oct. 2026, 20:41 UTC

DaVita Inc. saw a modest decline during after-market hours on Wednesday, moving to a loss of nearly one percent as it trades near its one-month range low.

8 oct. 2026, 20:07 UTC

DaVita Inc's shares are trading higher, recovering slightly from an earlier low, but remain below their 20-day moving average.

7 oct. 2026, 20:08 UTC

DaVita Inc. shares fell sharply amid broader market weakness, retreating from a morning rise and closing down significantly since Tuesday's close.

6 oct. 2026, 21:10 UTC

DaVita Inc. has declined sharply in after-market trading, reaching its lowest point of the day and falling below its 20-day moving average.

2 oct. 2026, 20:07 UTC

DaVita Inc. shares are higher, having peaked early in the session, and remain above their opening level despite being near the lower end of their one-month range.

1 oct. 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting a modest increase since Wednesday's close, despite pulling back from an earlier session high.

28 sept. 2026, 20:07 UTC

DaVita Inc's shares fell amid rising crude oil prices and inflation concerns, following a broader market decline that has affected major technology stocks.

25 sept. 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting broader market gains, despite earlier pulling back from a session high and remaining below its 20-day moving average.

24 sept. 2026, 20:01 UTC

DaVita Inc shares fell, marking a shift in momentum after a streak of higher daily closes in recent sessions.

18 sept. 2026, 19:46 UTC

DaVita Inc is modestly higher, recovering from an initial decline, and is currently above its 20-day moving average within its one-month trading range.

17 sept. 2026, 22:31 UTC

DaVita Inc is trading higher in after-market hours, reaching a peak above its 20-day moving average and positioned near the midpoint of its one-month range.

16 sept. 2026, 20:10 UTC

DaVita Inc has gained ground during Wednesday's trading session, reaching a peak earlier and remaining significantly above its 20-day moving average.

15 sept. 2026, 23:56 UTC

DaVita Inc shares are lower in after-market trading amid negative sentiment following a sharp decline in the NY Empire State Manufacturing Index.

14 sept. 2026, 23:41 UTC

DaVita Inc. shares declined in after-market trading, reflecting broader market trends amid rising crude oil prices and inflationary concerns.

11 sept. 2026, 20:51 UTC

DaVita Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

9 sept. 2026, 20:07 UTC

DaVita Inc. is higher in Wednesday trading, recovering from an early decline. The stock remains above its 20-day moving average and near a one-month peak.

8 sept. 2026, 20:04 UTC

DaVita Inc is trading lower today amid a decline in the Health Care Services sub-sector and broader market weakness. No specific company news was identified.

3 sept. 2026, 20:07 UTC

DaVita Inc shares are higher during Thursday's session, maintaining an upward trend since Wednesday's close amid a broader market rally and declining Treasury yields.

31 août 2026, 20:02 UTC

DaVita Inc's shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing the decline amid rising interest rate expectations.

Comparaison

Variation de prix

DaVita Inc prévision

Objectif de Prix

By TipRanks

24.82% hausse

Prévisions sur 12 Mois

Moyen 231.833 USD  24.82%

Haut 287 USD

Bas 180 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

3

Achat

2

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat